Close
FINDING CURES TOGETHER<sup>SM</sup>
  • Home
  • Award-Lectureship Detail

AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research

Nomination Status Open
Nomination Deadline 09/05/2018


Description

The AACR has established this Award in recognition of extraordinary contributions of Waun Ki Hong, MD advances in cancer research, cancer care, and cancer prevention during his longstanding brilliant career as a physician-scientist. This award will recognize a worthy cancer researcher who has conducted highly meritorious translational and clinical cancer research anywhere in the world. The award will honor an outstanding researcher who has not yet reached 51 years of age at the time of the award presentation.

The recipient of the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research will receive an honorarium of $10,000. In addition, he or she will be provided support to attend the AACR Annual Meeting 2019 to be held March 30-April 3, 2019 in Atlanta, Georgia and will be invited to give a 30-minute award lecture during the meeting.

Eligibility Criteria

  • Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
  • Candidates must have not yet reached 51 years of age at the time the award is received.
  • The Award will be presented to an individual investigator.
  • Institutions or organizations are not eligible for the Award.
  • Selection of the Award winner will be made based on the candidates' achievements in translational and clinical cancer research. No regard will be given to race, gender, nationality, geographic location, or religious or political views.

Contact Information

awards@aacr.org

Nomination Procedure

Nominations must be submitted online at myaacr.aacr.org by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Nominations must be submitted online at myaacr.aacr.org. Paper nominations cannot be accepted.

Nomination Materials

1) Nomination Letter Must:

  • be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
  • specify the AACR Award for which the candidate is being nominated;
  • contain a concise description of the candidate's meritorious achievement in translational and clinical cancer research, with the publications supporting these accomplishments directly referenced within the letter; and
  • contain a concise description of the impact of these accomplishments on the field.
  • be signed with a handwritten signature by the nominator(s).

 

2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications. Word (*.doc) and PDF (*.pdf) formatted files will be accepted.

3) Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

The preferred file format is *.pdf. 

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist.

There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

See the Program Guidelines and Nomination Instructions

Adobe Reader 

Selection Process

The Committee, appointed annually by the AACR President and representing the research areas to be honored, shall review all nominations for that year's AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research and shall select a nominee and an alternate in recognition of meritorious achievement in translational and clinical cancer research. The awardee must have not yet reached 51 years of age at the time of the award presentation. The Committee shall make its selection solely based on the candidate's scientific accomplishments, without regard to race, gender, nationality, geographic location, or religious or political views. The Committee shall forward its recommendations to the Executive Committee of the AACR for final consideration and decision.